Figure 5 (in comparison with Figure 3) demonstrates that there was no consistent relationship between CRT, measured by TOPflash activity, and changes in either total β-catenin protein levels, nuclear β-catenin localisation or cyclin D1 protein levels in SW480 human CRC cells treated with NSAIDs. This evidence concerns the gene CCND1 and colorectal carcinoma.